Skip to main content

LEGN · Legend Biotech Corp · Analyst Estimates

Track LEGN — free
$18.57 -0.75 (-3.88%) At close · Oct 2
Market Cap
$3.72B
Shares
194.49M
Volume · Oct 2 2.53M Avg daily vol (3M) 2.34M

Analyst Estimates

Compare analyst forecasts for Legend Biotech Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-02 12:56 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.01
-0.01
-0.01
—
-0.01
0.302
-0.01
0.302
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
1
0
0
0
Revenue
USD
Publication date not stated
1391500000
1430578260
1474000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
10
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.3162
0.6831
1.05
—
0.88405
1.20621
0.6831
1.30067
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
1615000000
1792352580
1927000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
10
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.01
0.01
0.01
—
0.01
0.1
0.01
0.1
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
340953000
358806560
378700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.09
0.09
0.09
—
0.09
0.16
0.09
0.16
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
357948000
381201220
399740000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —
Key facts CIK 1801198 CUSIP 52490G102 13F (30d) 5 filings 5 filers Visit website Investor relations